AQR Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-9,665
| Closed | -$93K | – | 2350 |
|
|
2022
Q2 | $93K | Buy |
9,665
+7,801
| +419% | +$75.1K | ﹤0.01% | 2099 |
|
|
2022
Q1 | $22K | Buy |
+1,864
| New | +$22K | ﹤0.01% | 2202 |
|
|
2021
Q2 | – | Sell |
-1,967
| Closed | -$147K | – | 2311 |
|
|
2021
Q1 | $147K | Sell |
1,967
-723
| -27% | -$54K | ﹤0.01% | 2138 |
|
|
2020
Q4 | $292K | Sell |
2,690
-1,943
| -42% | -$211K | ﹤0.01% | 1982 |
|
|
2020
Q3 | $410K | Buy |
4,633
+720
| +18% | +$63.7K | ﹤0.01% | 1805 |
|
|
2020
Q2 | $417K | Buy |
3,913
+2,450
| +167% | +$261K | ﹤0.01% | 1800 |
|
|
2020
Q1 | $87K | Buy |
+1,463
| New | +$87K | ﹤0.01% | 1974 |
|